Join us for the 2nd VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology
We are delighted to invite you to the second edition of the VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology, a first-class event bringing together leading national and international experts in the field.
Organized by the Vall d’Hebron Institute of Oncology (VHIO) with the support of the BBVA Foundation, this symposium will provide a cutting-edge assessment of current advancements, as well as an insightful look into the future of cell-based therapies in oncology.
We look forward to welcoming you to Barcelona for an inspiring event!
We are delighted to invite you to the second edition of the VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology, a first-class event bringing together leading national and international experts in the field.
Organized by the Vall d’Hebron Institute of Oncology (VHIO) with the support of the BBVA Foundation, this symposium will provide a cutting-edge assessment of current advancements, as well as an insightful look into the future of cell-based therapies in oncology.
We look forward to welcoming you to Barcelona for an inspiring event!
Information
Date: November 13-14, 2025
Location: Recinte Modernista de Sant Pau (Sant Pau Art Nouveau Site), Barcelona, Spain.
Target Audience: This symposium is designed for scientists, researchers, clinicians, patient representatives, and students interested in the latest breakthroughs in cell-based cancer therapies.
Alena Gros
Annette Künkele-Langer
Carlos Fernández de Larrea
Corina Amor
Cristina Puig Saus
Gloria González Aseguinolaza
Judith Feucht
Martí Farrera-Sal
Roberto Chiarle
Saar Gill
Silvia Martin Lluesma
Sine Reker Hadrup
Sonia Guedan
Suman Mitra
Thomas Blankenstein
Udai Kammula
Manel Juan
Cristina Castilla Llorente
Miquel Salas
Francisco Martin
Marta Puyol
Joaquin Arribas
Luis Álvarez-Vallina
Register now
Abstract Submission deadline: September 14th | Registration Deadline: October 1st
The 1st VHIO-BBVA Foundation International Symposium on Cell-based Therapies in Oncology, organised by Dr. Alena Gros, head of the VHIO Tumour Immunotherapy & Immunology Group, and Dr. Sonia Guedan, leader of the IDIBAPS Cellular Immunotherapies for Cancer Research Group, is due to be held on 29 and 30 November.
Location: Recinte Modernista de Sant Pau (Sant Pau Art Nouveau Site), Barcelona, Spain.
Target Audience: This symposium is designed for scientists, researchers, clinicians, patient representatives, and students interested in the latest breakthroughs in cell-based cancer therapies.
Program
This edition will address a variety of topics including determinants of ACT activity, adoptive cell therapies in solid cancers, pediatric malignancies, early clinical development in cell therapies, the regulatory framework in Europe, and more!
*Preliminary program, still subject to change.
Speakers
Alena Gros
Vall d’Hebron Institute of Oncology (VHIO), Spain
Annette Künkele-Langer
Charité – Universitätsmedizin Berlin, Germany
Carlos Fernández de Larrea
IDIBAPS - Hospital Clínic Barcelona, Spain
Corina Amor
Cold Spring Harbor Laboratory, United States
Cristina Puig Saus
University of California, Los Angeles (UCLA), United States
Gloria González Aseguinolaza
Clínica Universidad de Navarra - Hospital (CUN), Spain
Judith Feucht
University Children's Hospital Tübingen, Germany
Martí Farrera-Sal
Vall d’Hebron Institute of Oncology (VHIO), Spain
Roberto Chiarle
Harvard Medical School / University of Turin, Italy
Saar Gill
University of Pennsylvania, United States
Silvia Martin Lluesma
Vall d’Hebron Institute of Oncology (VHIO), Spain
Sine Reker Hadrup
Technical University of Denmark, Denmark
Sonia Guedan
IDIBAPS - Hospital Clínic Barcelona, Spain
Suman Mitra
University of Lille, France
Thomas Blankenstein
MDC Berlin, Germany
Udai Kammula
University of Pittsburgh, United States
Manel Juan
IDIBAPS - Hospital Clínic Barcelona, Spain
Cristina Castilla Llorente
Gustave Roussy, France
Miquel Salas
Biocat, Spain
Francisco Martin
SETGYC/ GENYO, Spain
Marta Puyol
Asociación Española Contra el Cáncer (AECC), Spain
Joaquin Arribas
Vall d'Hebron Institute of Oncology, IMIM, Spain
Luis Álvarez-Vallina
Hospital Del Mar Research Institute, Spain
Register to VHIO-BBVA Foundation Symposium
Register now
Abstract Submission deadline: September 14th | Registration Deadline: October 1st
Highlights from the 1st edition
The 1st VHIO-BBVA Foundation International Symposium on Cell-based Therapies in Oncology, organised by Dr. Alena Gros, head of the VHIO Tumour Immunotherapy & Immunology Group, and Dr. Sonia Guedan, leader of the IDIBAPS Cellular Immunotherapies for Cancer Research Group, is due to be held on 29 and 30 November.
The Vall d’Hebron Institute of Oncology (VHIO), a reference center for personalized medicine in oncology, was created in 2006. Thanks to its pioneering multidisciplinary and translational research model and its participation in consortia and projects with other prestigious centers worldwide, it has positioned itself as one of Europe's most important comprehensive centers. VHIO is capable of transforming, in record time, the latest research discoveries in the laboratory in early clinical trials and, therefore, in new opportunities for cancer patients, including cell therapies.
The BBVA Foundation promotes knowledge through research, artistic endeavors, and cultural creations. In collaboration with VHIO, the Foundation established the pioneering Comprehensive Program of Cancer Immunotherapy & Immunology (CAIMI) in 2017. This program has significantly improved VHIO's research in Immuno-Oncology, as well as advanced the development of cell therapies. As a result of this valuable support, we are delighted to present the inaugural symposium, which aims to disseminate high-quality research findings and foster collaboration among international experts to advance our understanding of cancer.
Supported by:
For general information please email us at symposium2025@vhio.net
